期刊文献+

磷脂酰肌醇蛋白聚糖3的原核表达及单克隆抗体制备 被引量:1

Expression and Antibody Preparation of Glypican 3
下载PDF
导出
摘要 人磷脂酰肌醇蛋白聚糖3(GPC3)是一个肝癌潜在的诊断标志物和治疗靶点。为获得抗GPC3单克隆抗体,用PCR方法克隆GPC3基因,利用酶切位点将该序列插入pGEX-2T载体,构建了pGEX-2T-gpc3表达载体。转化大肠杆菌BL21(DE3)菌株,经IPTG诱导,获得高效表达。经纯化后获得分子量为58 kD的蛋白。以该重组蛋白为免疫原,通过免疫BALB/c小鼠,经过细胞融合和筛选获得1株抗该重组蛋白的单克隆抗体1F3。Western blot分析显示,该抗体具有较好的特性,可用于GPC3蛋白的功能和应用研究。 Human glypican3 protein is a potential cancer therapeutic targets and diagnostic markers. In order to obtain anti-GPC3 monoclonal antibody, GPC3 gene was cloned into an expression vector pGEX-2T, which was transformed into E. coli BL21(DE3). Induced by IPTG, a molecular weight of 58 kD protein was obtained. After immunizing BALB/c mice, cell fusion and screening, one monoclonal antibody was generated. Western blot analysis revealed that the antibody has a strong specificity and high titer can be used for GPC3 protein function and applied research.
出处 《生物技术通报》 CAS CSCD 北大核心 2014年第3期177-181,共5页 Biotechnology Bulletin
基金 河北省科学院科技攻关项目(13335)
关键词 磷脂酰肌醇蛋白聚糖 3 蛋白表达 单克隆抗体 Glypican-3 Protein expression Monoclonal antibody
  • 相关文献

参考文献17

  • 1Pilia G. Hughes-Benzie RM. MacKenzie A. et al. Mutations in GPC3.a glypican gene, cause the Simpson-Golabi-Behmet overgrowthsyndrome [ J ] . Nat Genet, 1996, 12 ( 3 ) : 241-247.
  • 2Huber R, Crisponi L, Mazzarella R, et al. Analysis of exon/intron structure and 400 kb of genomic sequence surrounding the 5'- promoter and 3'-terminal ends of the human glypican 3 ( GPC3 ) gene [ J ] . Genomics, 1997, 45 ( 1 ) : 48-58.
  • 3Huber R, Mazzarella R, Chen CN, et al. Glypican 3 and glypican 4 are juxtaposed in Xq26.1 [ J ] . Gene, 1998, 225 ( 1-2 ) : 9-16.
  • 4Veugelers M, De Cat B, Ceulemans H, et al. Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans [ J ]. J Biol Chem, 1999, 274 ( 38 ) : 26968-77.
  • 5Filmus J. Glypicans : proteoglycans with a surprise [ J ] . Glycobiol- ogy, 2001, 11 (3): 19-23.
  • 6Shirakawa H, Kuronuma T, Nishimura Y, et al. Glypican-3 is a useful diagnostic marker for a component of hepatoeellular carcinoma in human liver cancer [ J ] . Int J Oneol, 2009, 34 ( 3 ) : 649-56.
  • 7Yasuda E, Kumada T, Toyoda H, et al. Evaluation for clinical utility of GPC3, measured by a commercially available ELISA kit with Gly- pican-3 ( GPC3 ) antibody, as a serological and histological marker for hepatocellular carcinoma [ J ] . Hepatol Res, 2010, 40 ( 5 ) : 477-485.
  • 8Shirakawa H, Suzuki H, Shimomura M, et al.Glypican-3 expression is correlated with poor prognosis in hepatoeellular carcinoma [ J ] . Cancer Sci, 2009, 100 ( 8 ) : 1403-1407.
  • 9Tangkijvanich P, Chanmee T, Komtong S, et al. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers [ J ] . J Gastroenterol Hepatol, 2010, 25 ( 1 ) : 129-37.
  • 10Filmus J, Capurro M. Glypican-3 : a marker and a therapeutic target in hepatoeellular carcinoma [ J ] . FEBS J, 2013, 280 ( 10 ): 2471-6.

二级参考文献9

共引文献380

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部